Delivery Order SPE2DB24D9131-SPE2DB25FXRT3
- Not listed
- The Defense Logistics Agency awarded a $1,547.40 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of XOLAIR 150 mg/ml syringes. The contract is firm fixed-price with an ultimate completion date of September 18, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million...
- The Defense Logistics Agency awarded a $38,685 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of XOLAIR 150 mg/ml syringes. This firm fixed-price delivery order, issued on September 17, 2025, with an ultimate completion date of October 8, 2025, represents a discrete purchase under the agency's broader pharmaceutical supply framework. The contract contains no set-aside designation, allowing...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $15,474.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of XOLAIR 150 MG/ML syringes. The award, issued on September 16, 2025, with an ultimate completion date of October 7, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order for XOLAIR 150 MG/ML syringes valued at $3,094.80. The contract, which was awarded on September 8, 2025, with an ultimate completion date of September 29, 2025, carries firm fixed-price terms and does not utilize a set-aside designation. This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,547.40 to DMS Pharmaceutical Group Inc. for the supply of XOLAIR 150 mg/ml syringes. The contract is firm fixed price with no set-aside designation and is scheduled for ultimate completion on October 10, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its location in Park Ridge, IL. This delivery order is issued under...
- The Defense Logistics Agency has awarded a delivery order valued at $3,868.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the provision of Xolair 150 mg/ml syringes. The contract is firm fixed-price with an ultimate completion date of September 17, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the...
- The Defense Logistics Agency awarded a delivery order valued at $7,737.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of XOLAIR 150 mg/ml syringes. This firm fixed-price delivery order, issued on September 10, 2025, is scheduled for ultimate completion by October 1, 2025, with performance taking place at the awardee's Park Ridge facility. The contract was awarded without a set-aside designation,...
- The Defense Logistics Agency awarded a $9,284.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 75 mg/0.5 mL syringes. The contract, issued on September 17, 2025, with an ultimate completion date of October 8, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,094.80 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml syringes. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery at its Park Ridge location with an ultimate completion date of October 2, 2025. This delivery order was issued without a set-aside designation, leveraging the company's competitive capabilities...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XOLAIR 150 MG/ML SYRINGEML. The potential value of the order is $1,547.42 with a completion date of February 26, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of branded and generic pharmaceutical products to U.S. government agencies, particularly the...
- SPE2DB24D9131Indefinite Delivery Contract
- SPE2DB24D9131-SPE2DB25FXRT3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,547.40 to DMS Pharmaceutical Group Inc. for XOLAIR 150 mg/ml syringes on August 25, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a single pharmaceutical product delivery to support Department of Defense healthcare operations. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor for this delivery, leveraging its established position as a critical supplier within the federal pharmaceutical supply chain. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products, biologics, and medical consumables to support military health facilities worldwide. The award of this delivery order for XOLAIR—a biologic medication used for asthma and chronic urticaria treatment—demonstrates the ongoing utilization of this master contract vehicle for targeted pharmaceutical resupply needs. DMS Pharmaceutical Group's performance as a woman-owned small business has established it as a preferred vendor for the Defense Logistics Agency's pharmaceutical distribution requirements across the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/25/25 |